Sector
HealthcareOpen
₹889.9Prev. Close
₹890.25Turnover(Lac.)
₹282.89Day's High
₹900Day's Low
₹87852 Week's High
₹1,05552 Week's Low
₹571.4Book Value
₹108.59Face Value
₹10Mkt Cap (₹ Cr.)
4,702.9P/E
49.39EPS
18.07Divi. Yield
2.352 Aug 2024
12:00 AM
AGM
Announcement Date: 02 Aug, 2024
15 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
14 May 2024
12:00 AM
Dividend
Dividend Amount: 18
Record Date: 16 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 87.14 | 71.85 | 52.9 | 52.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 426.67 | 449.19 | 467.8 | 392.59 |
Net Worth | 513.81 | 521.04 | 520.7 | 445.46 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 561.53 | 474.27 | 400 | 331.79 |
yoy growth (%) | 18.39 | 18.56 | 20.55 | 11.51 |
Raw materials | -165.23 | -160.55 | -112.34 | -90.84 |
As % of sales | 29.42 | 33.85 | 28.08 | 27.37 |
Employee costs | -58.82 | -56.79 | -45.75 | -32.48 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 207.38 | 161.28 | 156.33 | 150.15 |
Depreciation | -28.47 | -21.08 | -19.54 | -12.08 |
Tax paid | -55.33 | -41.51 | -32.68 | -51.92 |
Working capital | 67.33 | 22.23 | -22.08 | -14.1 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 18.39 | 18.56 | 20.55 | 11.51 |
Op profit growth | 35.19 | 2.41 | 19.92 | 21.17 |
EBIT growth | 29.52 | 2.72 | 4.7 | 31.56 |
Net profit growth | 26.95 | 50.99 | -17.4 | 105.78 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 687.35 | 571.88 | 526.67 | 588.86 | 494.62 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 687.35 | 571.88 | 526.67 | 588.86 | 494.62 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 14.83 | 9.76 | 9.6 | 29.25 | 12.43 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,107.4 | 131.82 | 1,07,645.29 | 138.24 | 0.14 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,992.5 | 83.66 | 1,00,542.86 | 341.6 | 0.23 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 667.2 | 250.04 | 50,401.01 | 39.56 | 0.15 | 366.87 | 120.23 |
Narayana Hrudayalaya Ltd NH | 1,775.8 | 84.57 | 36,292.44 | 79.22 | 0.23 | 865.04 | 95.32 |
Global Health Ltd MEDANTA | 1,177.8 | 80.59 | 31,624.82 | 99.31 | 0 | 624.4 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Company Sec. & Compli. Officer
RAMJEE DORAI
Independent Director
Indumati Gopinathan
Non-Exec & Non-Independent Dir
Dhaval Shah
Non-Exec & Non-Independent Dir
Dharmil Sheth
Chairman & MD & CEO
Rahul Guha
Non-Exec & Non-Independent Dir
Hardik Dedhia
Independent Director
Prapti Ishwar Gilada
Independent Director
Harshil Jiten Vora
Independent Director
Nishant A. Shah
Independent Director
Anandh Sundar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Thyrocare Technologies Ltd
Summary
Thyrocare Technologies Limited was incorporated in January, 2000. The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases. Their 43 profiles are administered under its reputed Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs). The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of Thyrocare Technologies, is engaged in PET-CT Scan imaging diagnostic business. NHL currently has 10 active operating PET-CT scanners in 8 imaging centers: two in Navi Mumbai, two in New Delhi, one each in Hyderabad, Central Mumbai, Western Mumbai, Baroda, Nashik and Bangalore. NHL also owns and operates a medical cyclotron unit in Nav
Read More
What is the Thyrocare Technologies Ltd share price today?
The Thyrocare Technologies Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹887.45 today.
What is the Market Cap of Thyrocare Technologies Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Thyrocare Technologies Ltd is ₹4702.90 Cr. as of 30 Apr ‘25
What is the PE and PB ratio of Thyrocare Technologies Ltd?
The PE and PB ratios of Thyrocare Technologies Ltd is 49.39 and 8.81 as of 30 Apr ‘25
What is the 52 Week High and Low of Thyrocare Technologies Ltd?
The 52-week high/low is the highest and lowest price at which a Thyrocare Technologies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Thyrocare Technologies Ltd is ₹571.4 and ₹1055 as of 30 Apr ‘25
What is the CAGR of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd's CAGR for 5 Years at 11.50%, 3 Years at 3.16%, 1 Year at 36.82%, 6 Month at -5.71%, 3 Month at 13.16% and 1 Month at 23.35%.
What is the shareholding pattern of Thyrocare Technologies Ltd?
The shareholding pattern of Thyrocare Technologies Ltd is as follows:
Promoters - 71.06 %
Institutions - 17.38 %
Public - 11.56 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
